Skip to main content
Cancer Science logoLink to Cancer Science
. 2019 Jul 4;110(7):2311. doi: 10.1111/cas.14097

Correction

PMCID: PMC6609807  PMID: 31273884

In an article1 titled “Antitumor activity of Raddeanin A is mediated by Jun amino‐terminal kinase activation and signal transducer and activator of transcription 3 inhibition in human osteosarcoma” by Zhuoying Wang, Jiakang Shen, Wei Sun, Tao Zhang, Dongqing Zuo, Hongsheng Wang, Gangyang Wang, Jing Xu, Fei Yin, Min Mao, Zifei Zhou, Yingqi Hua, Zhengdong Cai, the affiliation of Zhengdong Cai should be corrected:

Zhuoying Wang1, Jiakang Shen1,2, Wei Sun1, Tao Zhang1, Dongqing Zuo1, Hongsheng Wang1, Gangyang Wang1, Jing Xu1, Fei Yin1, Min Mao1, Zifei Zhou1, Yingqi Hua1, Zhengdong Cai1,2

1Department of Orthopaedics, Shanghai Bone Tumor Institute, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

2Shanghai General Hospital of Nanjing Medical University, Shanghai, China

The authors apologize for the error.

REFERENCE

  • 1. Wang Z, Shen J, Sun W, et al. Antitumor activity of Raddeanin A is mediated by Jun amino‐terminal kinase activation and signal transducer and activator of transcription 3 inhibition in human osteosarcoma. Cancer Sci. 2019;110:1746‐1759. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Science are provided here courtesy of Wiley

RESOURCES